Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 to $17 per share. | Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price between $15 and $17 per share.

Navan's shares started trading 12% below their initial public offering price on Thursday, as the travel technology company faced choppy market conditions amid a prolonged U.S. government shutdown.

Navan priced its IPO at $25 per share, aiming to raise around $700 million, with shares set to begin trading on Nasdaq. The company has grown through both organic expansion and strategic acquisitions, and plans to continue acquiring companies post-IPO.

According to a filing with the Securities and Exchange Commission dated October 20, 2025, Renaissance Capital reported a new stake in Circle Internet Group, purchasing 51,208 shares during the third quarter.

OpenAI is laying the groundwork for an initial public offering that could value the company at up to $1 trillion, three people familiar with the matter said, in what could be one of the biggest IPOs of all time.

The IPO preparations follow a restructuring of OpenAI completed on October 28 that reduced the company’s reliance on Microsoft, which has committed to investments of $13 billion and now owns about 27 percent of the company. OpenAI was most recently valued around $500 billion in private markets.

Doncasters Group, the nearly 250-year-old British metal engineering firm and longtime supplier to Boeing (BA), is considering an initial public offering in New York, Bloomberg News reported Wednesday,

Doncasters Group, an almost 250-year-old UK metal engineering group that supplies Boeing, is exploring an initial public offering in New York to tap rising investor demand for civil and military aerospace suppliers,

Capital raising offers a chance to boost capital spending. Private investment has been stagnant at about 10% of GDP— disappointing given the government’s ambition that India be a developed country by 2047. Corporate-tax cuts in 2019 have failed to spur a revival. A planned deregulatory push may give firms more reason to spend.